# Probiotic Skin Health Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/probiotic-skin-health-randomized-trial-evidence-review
Category: evidence-review
Summary: Probiotic Skin Health Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are 
Last reviewed: 2026-06-27
Reviewed by: Migaku Evidence Review
# Probiotic Skin Health Randomized Trial: What the Evidence Says

## Quick Answer

Probiotic Skin Health Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Human Microbiome Alterations in Antarctic Isolated, Confined, and Extreme (ICE) Environments: A Systematic Review and Meta‐Regression | systematic review | 1 | 2026-05-06 | 10.1155/ijm/3405549 |
| The Role of Biotics in Rosacea: A Narrative Review. | preclinical study | 4 | 2026-03-24 | 10.7759/cureus.105799 |

## What The Sources Report

- The oral microbiota, which contains the second-largest microbial load, has been associated with inflammatory processes and is increasingly recognized for its influence on both oral and systemic health. [Rumão Mateus S. (2026); evidence level 1]
- The review found that these environments can affect microbial diversity and taxonomic abundance. [Rumão Mateus S. (2026); evidence level 1]
- This narrative review evaluates current evidence regarding the role of biotics in rosacea. [Avendaño-Pérez AL (2026); evidence level 4]
- Evidence supporting the use of prebiotics, postbiotics, and synbiotics in rosacea remains limited and, in many cases, extrapolated from related inflammatory conditions or preclinical models. [Avendaño-Pérez AL (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For probiotic skin health randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Rumão Mateus S. (2026). Human Microbiome Alterations in Antarctic Isolated, Confined, and Extreme (ICE) Environments: A Systematic Review and Meta‐Regression. DOI: 10.1155/ijm/3405549. PMCID: PMC13149223. PMID: 42110715. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13149223/
- Avendaño-Pérez AL (2026). The Role of Biotics in Rosacea: A Narrative Review.. DOI: 10.7759/cureus.105799. PMCID: PMC13106664. PMID: 42037847. https://pmc.ncbi.nlm.nih.gov/articles/PMC13106664/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.